As the clinical trial proceeds, researchers will be monitoring the following: how effectively the vaccine treats HER2/neu- positive breast cancer, whether it restores drug sensitivity in those who have become drug resistant, whether it can prevent aggressive forms of breast cancer, and what specific side effects it has (Karmanos Cancer Institute,2008)